Clinical Trial Update: Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 feasibility trial evaluating navigational bronchoscopy-guided photodynamic therapy with Photofrin in unresectable peripheral lung cancer; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Metastasis
• Non-small Cell Lung Cancer

Drugs mentioned

• Photofrin (porfimer sodium)

Snippet

Sponsor: Concordia Laboratories Inc. | Conditions: Non-small Cell Lung Cancer (NSCLC), Lung Metastasis | Phase 1 | Status: COMPLETED | Results posted: 2020-01-21